These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21530644)

  • 1. Paraoxonase 1 protects macrophages from atherogenicity of a specific triglyceride isolated from human carotid lesion.
    Tavori H; Aviram M; Khatib S; Musa R; Mannheim D; Karmeli R; Vaya J
    Free Radic Biol Med; 2011 Jul; 51(1):234-42. PubMed ID: 21530644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284.
    Tavori H; Aviram M; Khatib S; Musa R; Mannheim D; Karmeli R; Vaya J
    Free Radic Biol Med; 2011 Jan; 50(1):148-56. PubMed ID: 21044882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism.
    Fuhrman B; Khateeb J; Shiner M; Nitzan O; Karry R; Volkova N; Aviram M
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1361-7. PubMed ID: 18436804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects.
    Tavori H; Aviram M; Khatib S; Musa R; Nitecki S; Hoffman A; Vaya J
    Free Radic Biol Med; 2009 Mar; 46(5):607-15. PubMed ID: 19103284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activation.
    Rosenblat M; Volkova N; Paland N; Aviram M
    Biofactors; 2012; 38(6):458-69. PubMed ID: 23047827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 attenuates human plaque atherogenicity: relevance to the enzyme lactonase activity.
    Tavori H; Vaya J; Aviram M
    Adv Exp Med Biol; 2010; 660():99-111. PubMed ID: 20221874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities.
    Aviram M; Hardak E; Vaya J; Mahmood S; Milo S; Hoffman A; Billicke S; Draganov D; Rosenblat M
    Circulation; 2000 May; 101(21):2510-7. PubMed ID: 10831526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
    Rozenberg O; Rosenblat M; Coleman R; Shih DM; Aviram M
    Free Radic Biol Med; 2003 Mar; 34(6):774-84. PubMed ID: 12633754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice.
    Rozenberg O; Shih DM; Aviram M
    Atherosclerosis; 2005 Jul; 181(1):9-18. PubMed ID: 15939049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion.
    Aviram M; Vaya J
    Curr Opin Lipidol; 2013 Aug; 24(4):339-44. PubMed ID: 23508039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress.
    Liu Y; Mackness B; Mackness M
    Free Radic Biol Med; 2008 Sep; 45(6):743-8. PubMed ID: 18585453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glabridin protects paraoxonase 1 from linoleic acid hydroperoxide inhibition via specific interaction: a fluorescence-quenching study.
    Atrahimovich D; Vaya J; Tavori H; Khatib S
    J Agric Food Chem; 2012 Apr; 60(14):3679-85. PubMed ID: 22380866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage paraoxonase 1 (PON1) binding sites.
    Efrat M; Aviram M
    Biochem Biophys Res Commun; 2008 Nov; 376(1):105-10. PubMed ID: 18762170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitro-Oleic Acid Reduces J774A.1 Macrophage Oxidative Status and Triglyceride Mass: Involvement of Paraoxonase2 and Triglyceride Metabolizing Enzymes.
    Rosenblat M; Rom O; Volkova N; Aviram M
    Lipids; 2016 Aug; 51(8):941-53. PubMed ID: 27344666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase 2 (PON2) decreases high glucose-induced macrophage triglycerides (TG) accumulation, via inhibition of NADPH-oxidase and DGAT1 activity: studies in PON2-deficient mice.
    Meilin E; Aviram M; Hayek T
    Atherosclerosis; 2010 Feb; 208(2):390-5. PubMed ID: 19748094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-Glutathionylation regulates HDL-associated paraoxonase 1 (PON1) activity.
    Rozenberg O; Aviram M
    Biochem Biophys Res Commun; 2006 Dec; 351(2):492-8. PubMed ID: 17070779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraoxonase 2 (PON2) expression is upregulated via a reduced-nicotinamide-adenine-dinucleotide-phosphate (NADPH)-oxidase-dependent mechanism during monocytes differentiation into macrophages.
    Shiner M; Fuhrman B; Aviram M
    Free Radic Biol Med; 2004 Dec; 37(12):2052-63. PubMed ID: 15544923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.